Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Romidepsin targets multiple survival signaling pathways in malignant T cells
Benigno C. Valdez, Jonathan E. Brammer, Yan Li, et al.
Blood Cancer Journal (2015) Vol. 5, Iss. 10, pp. e357-e357
Open Access | Times Cited: 65

Showing 26-50 of 65 citing articles:

R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin
Maryam Safari, Thomas Litman, Robert W. Robey, et al.
Molecular Cancer Research (2021) Vol. 19, Iss. 8, pp. 1361-1374
Open Access | Times Cited: 20
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype
Olasunkanmi O. Olaoye, P. R. Watson, Nabanita Nawar, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2691-2704
Open Access | Times Cited: 18
Recent Advances in Formulations for Long-Acting Delivery of Therapeutic Peptides
Parham Sahandi Zangabad, Zahra Abousalman‐Rezvani, Ziqiu Tong, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 9, pp. 3532-3554
Closed Access | Times Cited: 7
Epigenetic therapeutic strategies in pancreatic cancer
Arturo Orlacchio, Stephen Muzyka, Tamas A. Gonda
International review of cell and molecular biology (2024), pp. 1-40
Closed Access | Times Cited: 2
The role of aurora A and polo-like kinases in high-risk lymphomas
Carlos Murga‐Zamalloa, Kedar Inamdar, Ryan A. Wilcox
Blood Advances (2019) Vol. 3, Iss. 11, pp. 1778-1787
Open Access | Times Cited: 21
Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells
Yusuke Ito, Satoshi Inoue, Takahiro Nakashima, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. 1, pp. 141-153
Open Access | Times Cited: 6
Histone deacetylase inhibitors: targeting epigenetic regulation in the treatment of acute leukemia
Tong Xiao, Zhigang Chen, Yutong Xie, et al.
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 2
The contributory roles of histone deacetylases (HDACs) in hematopoiesis regulation and possibilities for pharmacologic interventions in hematologic malignancies
Mahdieh Mehrpouri, Atieh Pourbagheri‐Sigaroodi, Davood Bashash
International Immunopharmacology (2021) Vol. 100, pp. 108114-108114
Closed Access | Times Cited: 14
Epigenetics and Cutaneous Neoplasms: From Mechanism to Therapy
Frederick Gibson, Ailish Hanly, Robert Fisher, et al.
Epigenomics (2023) Vol. 15, Iss. 3, pp. 167-187
Closed Access | Times Cited: 5
Bioactivities by a crude extract from the GreenlandicPseudomonassp. In5 involves the nonribosomal peptides, nunamycin and nunapeptin
Charlotte Frydenlund Michelsen, Helle Jensen, Vincent J. Venditto, et al.
PeerJ (2015) Vol. 3, pp. e1476-e1476
Open Access | Times Cited: 15
PaDef (Persea americana var. drymifolia), a Plant Antimicrobial Peptide, Triggers Apoptosis, and Induces Global Epigenetic Modifications on Histone 3 in an Acute Lymphoid Leukemia Cell Line
Paola Jiménez-Alcántar, Rodolfo López-Gómez, Joel E. López‐Meza, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 8
Innovative Treatment Concepts for Cutaneous T-Cell Lymphoma Based on Microenvironment Modulation
Katharina Leuchte, Max Schlaak, Rudolf Stadler, et al.
Oncology Research and Treatment (2017) Vol. 40, Iss. 5, pp. 262-269
Open Access | Times Cited: 14
Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantation
Kayoko Tao, Yoshihiro Inamoto, Haruhi Furukawa, et al.
International Journal of Hematology (2023) Vol. 118, Iss. 2, pp. 292-298
Closed Access | Times Cited: 4
Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma
Josephine Yates, Camille Mathey-Andrews, Jihye Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses
Jonathan T. Lei, Lacey E. Dobrolecki, Chen Huang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma
Boaz Nachmias, Adir Shaulov, David Lavie, et al.
Acta Haematologica (2019) Vol. 141, Iss. 4, pp. 216-221
Closed Access | Times Cited: 10
Targeting epigenetic regulators in the treatment of T-cell lymphoma
Nada Ahmed, Andrew L. Feldman
Expert Review of Hematology (2020) Vol. 13, Iss. 2, pp. 127-139
Open Access | Times Cited: 10
Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
Caryn Sorge, Jenny McDaniel, Ana C. Xavier
Pharmaceuticals (2016) Vol. 9, Iss. 2, pp. 28-28
Open Access | Times Cited: 9
The Interplay between Dysregulated Metabolism and Epigenetics in Cancer
Mahmoud A. Bassal
Biomolecules (2023) Vol. 13, Iss. 6, pp. 944-944
Open Access | Times Cited: 3
Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials
Peipei Yang, Yali Tao, Ailin Zhao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells
Benigno C. Valdez, Jonathan E. Brammer, Yang Li, et al.
Leukemia Research (2016) Vol. 47, pp. 100-108
Open Access | Times Cited: 7
Complete remission with romidepsin in a patient with T‐cell acute lymphoblastic leukemia refractory to induction hyper‐CVAD
Mark W. Brunvand, John M. Carson
Hematological Oncology (2017) Vol. 36, Iss. 1, pp. 340-343
Open Access | Times Cited: 7
Synthesis and application of small molecules approved for the treatment of lymphoma
Yuanyuan Guo, Jingyi Zhang, Jinfeng Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115835-115835
Closed Access | Times Cited: 2
Molecular descriptors suggest stapling as a strategy for optimizing membrane permeability of cyclic peptides
Jianguo Li, Srinivasaraghavan Kannan, Pietro G. A. Aronica, et al.
The Journal of Chemical Physics (2022) Vol. 156, Iss. 6
Open Access | Times Cited: 4
The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors
Robert W. Robey, Christina M. Fitzsimmons, Wilfried M. Guiblet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4

Scroll to top